Neuroblastoma: The impact of biology and cooperation leading to personalized treatments
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroblastoma: The impact of biology and cooperation leading to personalized treatments
Authors
Keywords
-
Journal
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
Volume 49, Issue 3, Pages 85-115
Publisher
Informa UK Limited
Online
2012-05-31
DOI
10.3109/10408363.2012.683483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MIBG scoring as a prognostic indicator in patients with stage IV neuroblastoma: A COG study.
- (2017) G. A. Yanik et al. JOURNAL OF CLINICAL ONCOLOGY
- Moving Forward with Metronomic Chemotherapy: Meeting Report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology
- (2014) Eddy Pasquier et al. Translational Oncology
- Urine catecholamines in paediatrics
- (2011) D. J. Erdelyi et al. Archives of Disease in Childhood-Education and Practice Edition
- Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
- (2011) Jane E. Minturn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells
- (2011) Natalie Grinshtein et al. CANCER RESEARCH
- miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
- (2011) K. De Preter et al. CLINICAL CANCER RESEARCH
- Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor
- (2011) S. Kumar et al. CLINICAL CANCER RESEARCH
- High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
- (2011) J. H. Schulte et al. CLINICAL CANCER RESEARCH
- Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
- (2011) P. Castelo-Branco et al. CLINICAL CANCER RESEARCH
- Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings
- (2011) Anneleen Decock et al. Epigenetics
- The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma
- (2011) J. Stutterheim et al. EUROPEAN JOURNAL OF CANCER
- Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG project
- (2011) Paola Angelini et al. EUROPEAN JOURNAL OF CANCER
- Germline gain-of-function mutations of ALK disrupt central nervous system development
- (2011) Loïc de Pontual et al. HUMAN MUTATION
- Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age
- (2011) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Successful Multifold Dose Escalation of Anti-GD2Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study
- (2011) Brian H. Kushner et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2011) Wendy B. London et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term hepatic outcomes in survivors of stage 4S and 4 neuroblastoma in infancy
- (2011) Amy E. French et al. PEDIATRIC BLOOD & CANCER
- Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma
- (2011) Kelsey Johnson et al. PEDIATRIC BLOOD & CANCER
- Comparison of 123I-metaiodobenzylguanidine (MIBG) and 131I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: A report from the Children's Oncology Group
- (2011) Arlene Naranjo et al. PEDIATRIC BLOOD & CANCER
- PET-CT in children: where is it appropriate?
- (2011) Sue C. Kaste PEDIATRIC RADIOLOGY
- RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
- (2011) K. A. Cole et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
- (2011) Hervé J. Brisse et al. RADIOLOGY
- The MYCN oncogene and differentiation in neuroblastoma
- (2011) Ulrica K. Westermark et al. SEMINARS IN CANCER BIOLOGY
- Emerging importance of ALK in neuroblastoma
- (2011) Anna M. Azarova et al. SEMINARS IN CANCER BIOLOGY
- Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma
- (2011) Rebecca J. Deyell et al. Cancer Genetics
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
- (2011) Lễ B. Nguyễn et al. PLoS Genetics
- Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
- (2010) K K Matthay et al. BRITISH JOURNAL OF CANCER
- Clinical presentations and imaging findings of neuroblastoma beyond abdominal mass and a review of imaging algorithm
- (2010) C M Chu et al. BRITISH JOURNAL OF RADIOLOGY
- Identification of miRNAs that are associated with tumor metastasis in Neuroblastoma
- (2010) Jigang Guo et al. CANCER BIOLOGY & THERAPY
- Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy
- (2010) T. Martinsson et al. CANCER RESEARCH
- Neuroblastoma: Therapeutic strategies for a clinical enigma
- (2010) Shakeel Modak et al. CANCER TREATMENT REVIEWS
- Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
- (2010) K. De Preter et al. CLINICAL CANCER RESEARCH
- Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma
- (2010) R. Iyer et al. CLINICAL CANCER RESEARCH
- High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
- (2010) J. Carr-Wilkinson et al. CLINICAL CANCER RESEARCH
- Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
- (2010) S. De Brouwer et al. CLINICAL CANCER RESEARCH
- Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens
- (2010) Kristen M. Smith et al. EMBO Molecular Medicine
- Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project
- (2010) Veronica Moroz et al. EUROPEAN JOURNAL OF CANCER
- Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study
- (2010) Wendy B. London et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
- (2010) André Oberthuer et al. JOURNAL OF CLINICAL ONCOLOGY
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
- (2010) Ruth Ladenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1
- (2010) Hervé Rubie et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study
- (2010) Rochelle Bagatell et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuroblastoma Phox2b Variants Stimulate Proliferation and Dedifferentiation of Immature Sympathetic Neurons
- (2010) T. Reiff et al. JOURNAL OF NEUROSCIENCE
- Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
- (2010) Idoia Garcia et al. Molecular Cancer
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
- (2010) David L. Baker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Imaging in pediatric patients: Time to think again about surveillance
- (2010) Amy Lee Chong et al. PEDIATRIC BLOOD & CANCER
- Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: Results of German trials
- (2010) Thorsten Simon et al. PEDIATRIC BLOOD & CANCER
- Molecular Imaging of Neuroendocrine Tumors
- (2010) Jorge A. Carrasquillo et al. SEMINARS IN ONCOLOGY
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Clinical applications of biomarkers in pediatric traumatic brain injury
- (2009) Simon J. I. Sandler et al. CHILDS NERVOUS SYSTEM
- microRNA Profiling Identifies Cancer-Specific and Prognostic Signatures in Pediatric Malignancies
- (2009) J. S. Wei et al. CLINICAL CANCER RESEARCH
- Trk Receptor Expression and Inhibition in Neuroblastomas
- (2009) G. M. Brodeur et al. CLINICAL CANCER RESEARCH
- The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
- (2009) S. Fulda CURRENT CANCER DRUG TARGETS
- ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction
- (2009) Joffrey Degoutin et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma
- (2009) Brian H. Kushner et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [18F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma
- (2009) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Poor Survival for Infants WithMYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
- (2009) Adela Canete et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma WithoutMYCNGene Amplification
- (2009) Bruno De Bernardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the mTOR Signaling Network for Cancer Therapy
- (2009) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma
- (2009) S. E. Sharp et al. JOURNAL OF NUCLEAR MEDICINE
- Cystic fibrosis
- (2009) Brian P O'Sullivan et al. LANCET
- 59-gene prognostic signature sub-stratifies high-risk neuroblastoma patients
- (2009) Joëlle Vermeulen et al. LANCET ONCOLOGY
- Copy number variation at 1q21.1 associated with neuroblastoma
- (2009) Sharon J. Diskin et al. NATURE
- Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
- (2009) Mario Capasso et al. NATURE GENETICS
- The microRNA network and tumor metastasis
- (2009) H Zhang et al. ONCOGENE
- Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG
- (2009) Chizuko Okamatsu et al. PEDIATRIC BLOOD & CANCER
- VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE)
- (2009) Franck Bourdeaut et al. PEDIATRIC BLOOD & CANCER
- Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
- (2009) Isabella Bray et al. PLoS One
- 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures
- (2008) R Ladenstein et al. BONE MARROW TRANSPLANTATION
- Reference intervals for urinary catecholamines and metabolites from birth to adulthood
- (2008) Eric Pussard et al. CLINICAL BIOCHEMISTRY
- Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma
- (2008) I. Y. Cheung et al. CLINICAL CANCER RESEARCH
- ALARA: is there a cause for alarm? Reducing radiation risks from computed tomography scanning in children
- (2008) Nikhil Bharat Shah et al. CURRENT OPINION IN PEDIATRICS
- Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age
- (2008) Jan de Kraker et al. EUROPEAN JOURNAL OF CANCER
- The prognostic impact of functional imaging with 123I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: Results of the German Neuroblastoma Trial NB97
- (2008) Matthias Schmidt et al. EUROPEAN JOURNAL OF CANCER
- Management and outcome of stage 3 neuroblastoma
- (2008) Shakeel Modak et al. EUROPEAN JOURNAL OF CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- The kinesin KIF1B acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
- (2008) S. Schlisio et al. GENES & DEVELOPMENT
- KIF1Bβ Functions as a Haploinsufficient Tumor Suppressor Gene Mapped to Chromosome 1p36.2 by Inducing Apoptotic Cell Death
- (2008) Arasambattu K. Munirajan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PHOX2BIs a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma
- (2008) Janine Stutterheim et al. JOURNAL OF CLINICAL ONCOLOGY
- Retrospective Study of Childhood Ganglioneuroma
- (2008) Bruno De Bernardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Significance ofMYCNAmplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database
- (2008) Rochelle Bagatell et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Rare Occurrence of PHOX2b Mutations in Sporadic Neuroblastomas
- (2008) Alexandre Serra et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- CHD5 , a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas
- (2008) Tomoyuki Fujita et al. JNCI-Journal of the National Cancer Institute
- Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study
- (2008) Eiso Hiyama et al. LANCET
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
- (2008) Andrew DJ Pearson et al. LANCET ONCOLOGY
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
- A gene regulatory network orchestrates neural crest formation
- (2008) Tatjana Sauka-Spengler et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury
- (2008) Aslan Guzel et al. NEUROSURGICAL REVIEW
- N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma
- (2008) M S Hossain et al. ONCOGENE
- Identification of Genes Targeted by CpG Island Methylator Phenotype in Neuroblastomas, and Their Possible Integrative Involvement in Poor Prognosis
- (2008) Masanobu Abe et al. ONCOLOGY
- Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project
- (2008) Steven G. DuBois et al. PEDIATRIC BLOOD & CANCER
- Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group
- (2008) Peter E. Zage et al. PEDIATRIC BLOOD & CANCER
- Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: A report from the Children's Oncology Group
- (2008) Julie R. Park et al. PEDIATRIC BLOOD & CANCER
- Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial
- (2007) Thorsten Simon et al. PEDIATRIC BLOOD & CANCER
- Imaging Pediatric Abdominal Tumors
- (2007) Sue C. Kaste et al. SEMINARS IN ROENTGENOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now